Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-20 4:15 pm Purchase | 2021-04-12 | 13D | Lifecore Biomedical, Inc. LFCR | Wynnefield Partners Small Cap Value, L.P. I | 3,190,305 10.900% | 507,905![]() (+18.93%) | Filing History |
| 2021-03-25 4:27 pm Purchase | 2021-03-25 | 13G | Lifecore Biomedical, Inc. LFCR | Cove Street Capital LLC | 1,608,618 5.490% | 1,608,618![]() (New Position) | Filing History |
| 2021-02-12 5:13 pm Sale | 2021-02-16 | 13G | Lifecore Biomedical, Inc. LFCR | DIMENSIONAL FUND ADVISORS LP | 2,219,361 7.600% | -212,172![]() (-8.73%) | Filing History |
| 2021-02-10 11:14 am Purchase | 2020-12-31 | 13G | Lifecore Biomedical, Inc. LFCR | VANGUARD GROUP INC | 1,671,841 5.720% | 52,739![]() (+3.26%) | Filing History |
| 2021-01-29 5:23 pm Purchase | 2020-12-31 | 13G | Lifecore Biomedical, Inc. LFCR | BlackRock Inc. BLK | 2,091,030 7.200% | 79,319![]() (+3.94%) | Filing History |

